SHR2285

SHR2285 · Shanghai Hengrui Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SHR2285, covering 2025-11-17 to 2025-11-17. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study on the Efficacy and Safety of Multiple Oral Administrations of SHR2285 Tablets in Patients Undergoing Elective Total Knee Arthroplasty [Phase 2]

See pricing